No Data
Chengdu Huasun Technology Group's Capsules Intended for Selection for National TCM Procurement; Shares Down 4%
Chengdu huasun technology group Inc., LTD. (000790.SZ): Sanqi Tongshu capsules are proposed to be selected for centralized volume procurement.
Gelonghui January 2, Chengdu huasun technology group Inc., LTD. (000790.SZ) announced that the company participated in the national Chinese Patent Medicine procurement alliance centralized volume purchasing work. According to the "National Chinese Patent Medicine Procurement Alliance Centralized Volume Purchasing Proposed Selected Results Announcement" released by the Hubei Medical Insurance Service Platform on December 30, 2024, the company's product Sanchi Tongshu Capsules is proposed to be selected for this centralized volume procurement.
Huashen Technology: Report for the third quarter of 2024
chengdu huasun technology group inc., ltd. (000790.SZ): The net income in the first three quarters was 5.7379 million yuan, a year-on-year decrease of 72.79%.
Chengdu Huasun Technology Group Inc., Ltd. (000790.SZ) announced its third quarter report for 2024 on October 30th. The company achieved revenue of 0.663 billion yuan in the first three quarters, a decrease of 1.39% year-on-year; net income attributable to shareholders of the listed company was 5.7379 million yuan, a decrease of 72.79% year-on-year; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 5.1911 million yuan, a decrease of 81.30% year-on-year; basic earnings per share was 0.0091 yuan.
The Past One-year Earnings Decline for Chengdu Huasun Technology Group (SZSE:000790) Likely Explains Shareholders Long-term Losses
Chengdu huasun technology group Inc., LTD.: Half-year report for the year 2024.
Some Chengdu Huasun Technology Group Inc. , LTD. (SZSE:000790) Shareholders Look For Exit As Shares Take 28% Pounding
